Our previous11 and current findings revealed that detailed molecular mechanisms by glucocorticoids suppressed diabetes (ie inflammation and hypoxia)‐induced galectin‐1 expression via transactivation of DUSP‐1 and TSC22D3, respectively. This evidence concerns the gene DUSP1 and diabetes mellitus.